NGEN

NERVGEN PHARMA CORP

NGEN·64082X203·US·Common Stock·Healthcare - Biotechnology

NGEN (NERVGEN PHARMA CORP) is held by 27 institutional investors as of Q1 2026. Largest holders: BANK OF AMERICA CORP /DE/ ($756,473), MARSHALL WACE, LLP ($755,355), ROYAL BANK OF CANADA ($648,000). Net institutional sentiment: Bullish.

27
Holders
Avg rating(9 Elite)
$4.3M
Total Value
100% (27)
Fund Consensus
27 buying - 0 selling

No verdict yet — fewer than 2 funds hold NGEN.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
200,656$756,4730.0%-52.41%
34
New
200,359$755,3550.0%-52.41%
34
New
171,961$648,0000.0%-52.41%
34
New
86,815$327,2930.0%-52.41%
33
New
62,900$237,1330.0%-52.41%
32
New
62,367$235,1240.0%-52.41%
32
New
61,517$231,9190.0%-52.41%
35
New
39,991$150,7650.0%-52.41%
31
New
33,350$125,7300.0%-52.41%
31
New
31,400$118,3780.0%-52.41%
30
New
23,800$102,8480.0%-52.41%
30
New
13,462$78,6180.0%-52.41%
33
New
20,000$75,4000.0%-52.41%
33
New
17,875$67,3890.0%-52.41%
29
New
15,504$59,0000.0%-52.41%
32
New
13,400$50,5180.0%-52.41%
31
New
12,998$49,0750.0%-52.41%
28
New
12,937$48,7720.0%-52.41%
31
New
11,982$45,1720.0%-52.41%
31
New
10,560$39,8110.0%-52.41%
28

Showing 1-20 of 27

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used